{"transactions":[{"id":709561,"issuer":{"id":304,"kind":"organization","name":"SERA PROGNOSTICS, INC.","symbol":"SERA"},"owners":[{"id":30492,"kind":"person","name":"Barlow Jane F","position":1,"cik":"0001736026","reported_name":"Barlow Jane F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-14T22:41:04.000Z","date":"2026-07-10","kind":"grant","planned":false,"acquired":true,"shares":2998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the grant date; provided, however, that the stock options shall be fully vested on the earlier of the first anniversary of the grant date or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer."}],"balance_after":2998,"derivative":{"exercise_price":1.97,"expiration_date":"2036-07-10","underlying":"Class A Common Stock","underlying_shares":2998},"source":{"system":"sec-edgar","filing":"0001736026-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1534969/000173602626000002/ownership.xml","form_type":"4"}},{"id":709560,"issuer":{"id":304,"kind":"organization","name":"SERA PROGNOSTICS, INC.","symbol":"SERA"},"owners":[{"id":30492,"kind":"person","name":"Barlow Jane F","position":1,"cik":"0001736026","reported_name":"Barlow Jane F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-14T22:41:04.000Z","date":"2026-07-10","kind":"grant","planned":false,"acquired":true,"shares":34494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Consists of stock options granted pursuant to the issuer's Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the grant date; provided, however, that the stock options shall be fully vested on the earlier of the first anniversary of the grant date or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer."}],"balance_after":34494,"derivative":{"exercise_price":1.97,"expiration_date":"2036-07-10","underlying":"Class A Common Stock","underlying_shares":34494},"source":{"system":"sec-edgar","filing":"0001736026-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534969/000173602626000002/ownership.xml","form_type":"4"}},{"id":709559,"issuer":{"id":304,"kind":"organization","name":"SERA PROGNOSTICS, INC.","symbol":"SERA"},"owners":[{"id":30492,"kind":"person","name":"Barlow Jane F","position":1,"cik":"0001736026","reported_name":"Barlow Jane F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-07-14T22:41:04.000Z","date":"2026-07-10","kind":"grant","planned":false,"acquired":true,"shares":1949,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Each share is represented by an additional RSU granted by the Board of Directors. These RSUs vest on the earlier of July 10, 2027 or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer."}],"balance_after":47088,"source":{"system":"sec-edgar","filing":"0001736026-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534969/000173602626000002/ownership.xml","form_type":"4"}},{"id":709558,"issuer":{"id":304,"kind":"organization","name":"SERA PROGNOSTICS, INC.","symbol":"SERA"},"owners":[{"id":30492,"kind":"person","name":"Barlow Jane F","position":1,"cik":"0001736026","reported_name":"Barlow Jane F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-07-14T22:41:04.000Z","date":"2026-07-10","kind":"grant","planned":false,"acquired":true,"shares":22426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\") granted pursuant to the issuer's Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These RSUs vest on the earlier of July 10, 2027 or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer."}],"balance_after":45139,"source":{"system":"sec-edgar","filing":"0001736026-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534969/000173602626000002/ownership.xml","form_type":"4"}},{"id":1119241,"issuer":{"id":304,"kind":"organization","name":"SERA PROGNOSTICS, INC.","symbol":"SERA"},"owners":[{"id":30492,"kind":"person","name":"Barlow Jane F","position":1,"cik":"0001736026","reported_name":"Barlow Jane F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-06T22:37:33.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted pursuant to Sera Prognostics, Inc.'s Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 5, 2025."}],"balance_after":25000,"derivative":{"exercise_price":1.6,"expiration_date":"2035-06-05","underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950170-25-083332","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534969/000095017025083332/ownership.xml","form_type":"4"}},{"id":1119240,"issuer":{"id":304,"kind":"organization","name":"SERA PROGNOSTICS, INC.","symbol":"SERA"},"owners":[{"id":30492,"kind":"person","name":"Barlow Jane F","position":1,"cik":"0001736026","reported_name":"Barlow Jane F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-06T22:37:33.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":15596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). These RSUs vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 5, 2025, subject to the Reporting Person continuing to provide services to the issuer."}],"balance_after":22713,"source":{"system":"sec-edgar","filing":"0000950170-25-083332","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534969/000095017025083332/ownership.xml","form_type":"4"}},{"id":1471088,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":30492,"kind":"person","name":"Barlow Jane F","position":1,"cik":"0001736026","reported_name":"Barlow Jane F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-24T19:43:06.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest each month following the date of grant, or if earlier 100% of the shares subject to the option shall vest on the date of the Issuer's next annual stockholder meeting, in each case subject to the reporting person remaining a Service Provider (as defined in the 2021 Equity Incentive Plan) through the applicable vesting date."}],"balance_after":50000,"derivative":{"exercise_price":0.569,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-24-076994","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000095017024076994/ownership.xml","form_type":"4"}},{"id":1486211,"issuer":{"id":304,"kind":"organization","name":"SERA PROGNOSTICS, INC.","symbol":"SERA"},"owners":[{"id":30492,"kind":"person","name":"Barlow Jane F","position":1,"cik":"0001736026","reported_name":"Barlow Jane F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-07T20:31:37.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":10549,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted pursuant to Sera Prognostics, Inc.'s Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer."}],"balance_after":10549,"derivative":{"exercise_price":8.43,"expiration_date":"2034-06-06","underlying":"Class A Common Stock","underlying_shares":10549},"source":{"system":"sec-edgar","filing":"0001534969-24-000131","document":"wk-form4_1717792288.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534969/000153496924000131/wk-form4_1717792288.xml","form_type":"4"}},{"id":1486210,"issuer":{"id":304,"kind":"organization","name":"SERA PROGNOSTICS, INC.","symbol":"SERA"},"owners":[{"id":30492,"kind":"person","name":"Barlow Jane F","position":1,"cik":"0001736026","reported_name":"Barlow Jane F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-07T20:31:37.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":7117,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). These RSUs vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer."}],"balance_after":7117,"source":{"system":"sec-edgar","filing":"0001534969-24-000131","document":"wk-form4_1717792288.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534969/000153496924000131/wk-form4_1717792288.xml","form_type":"4"}},{"id":1832726,"issuer":{"id":304,"kind":"organization","name":"SERA PROGNOSTICS, INC.","symbol":"SERA"},"owners":[{"id":30492,"kind":"person","name":"Barlow Jane F","position":1,"cik":"0001736026","reported_name":"Barlow Jane F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-07T20:23:46.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":63265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Consists of stock options granted pursuant to Sera Prognostics, Inc.'s Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 8, 2023."}],"balance_after":63265,"derivative":{"exercise_price":3,"expiration_date":"2033-06-08","underlying":"Class A Common Stock","underlying_shares":63265},"source":{"system":"sec-edgar","filing":"0001534969-23-000079","document":"wk-form4_1688761417.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534969/000153496923000079/wk-form4_1688761417.xml","form_type":"4"}},{"id":1861101,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":30492,"kind":"person","name":"Barlow Jane F","position":1,"cik":"0001736026","reported_name":"Barlow Jane F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-09T18:11:05.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest each month following the date of grant, or if earlier 100% of the shares subject to the option shall vest on the date of the Issuer's next annual stockholder meeting, in each case subject to the reporting person remaining a Service Provider (as defined in the 2021 Equity Incentive Plan) through the applicable vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.5,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-23-036000","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000120919123036000/doc4.xml","form_type":"4"}},{"id":2236527,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":30492,"kind":"person","name":"Barlow Jane F","position":1,"cik":"0001736026","reported_name":"Barlow Jane F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-10T16:51:24.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest each month following the date of grant, or if earlier 100% of the shares subject to the option shall vest on the date of the Issuer's next annual stockholder meeting, in each case subject to the reporting person remaining a Service Provider (as defined in the 2021 Equity Incentive Plan) through the applicable vesting date."}],"balance_after":40000,"derivative":{"exercise_price":3.24,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-22-035950","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000120919122035950/doc4.xml","form_type":"4"}},{"id":2265606,"issuer":{"id":116797,"kind":"organization","name":"CONTRAFECT Corp","symbol":"CFRX"},"owners":[{"id":30492,"kind":"person","name":"Barlow Jane F","position":1,"cik":"0001736026","reported_name":"Barlow Jane F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2022-05-18T20:12:43.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":42000,"price":3.35,"value":140700.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant award made under the ContraFect Corporation 2014 Omnibus Incentive Plan.  Grant vests over one year, 25% at the end of each quarter following the vesting commencement date."}],"balance_after":42000,"derivative":{"exercise_price":3.35,"expiration_date":"2032-05-17","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001209191-22-030285","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478069/000120919122030285/doc4.xml","form_type":"4"}},{"id":2298228,"issuer":{"id":304,"kind":"organization","name":"SERA PROGNOSTICS, INC.","symbol":"SERA"},"owners":[{"id":30492,"kind":"person","name":"Barlow Jane F","position":1,"cik":"0001736026","reported_name":"Barlow Jane F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-04-12T21:22:37.000Z","date":"2022-04-11","kind":"grant","acquired":true,"shares":140823,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options vest over three years as follows: 1/36 of the original grant amount vests in monthly installments for three years following the vesting commencement date, which is April 11, 2022."}],"balance_after":140823,"derivative":{"exercise_price":2.83,"expiration_date":"2032-04-11","underlying":"Class A Common Stock","underlying_shares":140823},"source":{"system":"sec-edgar","filing":"0001534969-22-000050","document":"wf-form4_164979854182714.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534969/000153496922000050/wf-form4_164979854182714.xml","form_type":"4"}},{"id":2600872,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":30492,"kind":"person","name":"Barlow Jane F","position":1,"cik":"0001736026","reported_name":"Barlow Jane F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-17T18:10:28.000Z","date":"2021-08-16","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One thirty-sixth (1/36) of the shares subject to the option shall vest monthly beginning on the one month anniversary of August 16, 2021 (the \"Vesting Commencement Date\"), subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each such date."}],"balance_after":80000,"derivative":{"exercise_price":9.19,"expiration_date":"2031-08-16","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001209191-21-052009","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000120919121052009/doc4.xml","form_type":"4"}},{"id":2866577,"issuer":{"id":116797,"kind":"organization","name":"CONTRAFECT Corp","symbol":"CFRX"},"owners":[{"id":30492,"kind":"person","name":"Barlow Jane F","position":1,"cik":"0001736026","reported_name":"Barlow Jane F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"OPTIONS (RIGHT TO BUY)","published_at":"2021-02-11T20:34:38.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the underlying shares on the date of grant and the remaining 75% of the total shares vest in equal annual installments on the first three anniversaries of the date of grant, subject to continued service with the issuer through each vesting date."}],"balance_after":16000,"derivative":{"exercise_price":5.89,"expiration_date":"2031-02-07","underlying":"COMMON STOCK","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0000899243-21-006062","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478069/000089924321006062/doc4.xml","form_type":"4"}},{"id":3018367,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":30492,"kind":"person","name":"Barlow Jane F","position":1,"cik":"0001736026","reported_name":"Barlow Jane F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:08:34.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with that certain Agreement and Plan of Merger, dated as of August 19, 2020, by and among Johnson & Johnson, Vigor Sub, Inc. and the Issuer, pursuant to which, effective immediately prior to the effective time of the merger contemplated thereby (the \"Effective Time\"), each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which $52.50 exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with that certain Agreement and Plan of Merger, dated as of August 19, 2020, by and among Johnson & Johnson, Vigor Sub, Inc. and the Issuer, pursuant to which, effective immediately prior to the effective time of the merger contemplated thereby (the \"Effective Time\"), each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which $52.50 exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":38.09,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-20-010058","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010058/edgar.xml","form_type":"4"}},{"id":3018366,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":30492,"kind":"person","name":"Barlow Jane F","position":1,"cik":"0001736026","reported_name":"Barlow Jane F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:08:34.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with that certain Agreement and Plan of Merger, dated as of August 19, 2020, by and among Johnson & Johnson, Vigor Sub, Inc. and the Issuer, pursuant to which, effective immediately prior to the effective time of the merger contemplated thereby (the \"Effective Time\"), each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which $52.50 exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with that certain Agreement and Plan of Merger, dated as of August 19, 2020, by and among Johnson & Johnson, Vigor Sub, Inc. and the Issuer, pursuant to which, effective immediately prior to the effective time of the merger contemplated thereby (the \"Effective Time\"), each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which $52.50 exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":15.71,"expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001179110-20-010058","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010058/edgar.xml","form_type":"4"}},{"id":3100852,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":30492,"kind":"person","name":"Barlow Jane F","position":1,"cik":"0001736026","reported_name":"Barlow Jane F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-24T17:45:31.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an option granted by the Company pursuant to the Company's 2013 Incentive Award Plan. The stock option will vest and become exercisable on the first anniversary of the grant date, subject to Dr. Barlow's continued service to the Company."}],"balance_after":25000,"derivative":{"exercise_price":38.09,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-20-007753","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020007753/edgar.xml","form_type":"4"}},{"id":3342171,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":30492,"kind":"person","name":"Barlow Jane F","position":1,"cik":"0001736026","reported_name":"Barlow Jane F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-13T16:18:24.000Z","date":"2019-12-11","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options granted by the issuer pursuant to the issuer's 2013 Incentive Award Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest and become exercisable with respect to 16,667 shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent two years. All vesting is subject to Dr. Barlow's continued service to the Company through the applicable vesting date."}],"balance_after":50000,"derivative":{"exercise_price":15.71,"expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001179110-19-012740","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019012740/edgar.xml","form_type":"4"}},{"id":3439571,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":30492,"kind":"person","name":"Barlow Jane F","position":1,"cik":"0001736026","reported_name":"Barlow Jane F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-14T20:33:51.000Z","date":"2019-08-12","kind":"purchase","acquired":true,"shares":3144,"price":3.18,"value":9997.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.17 to 3.18, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in Footnote (1) to this Form 4."}],"balance_after":3144,"source":{"system":"sec-edgar","filing":"0001387131-19-006151","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713119006151/ownership.xml","form_type":"4"}},{"id":3480824,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":30492,"kind":"person","name":"Barlow Jane F","position":1,"cik":"0001736026","reported_name":"Barlow Jane F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-06-24T23:00:46.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":75000,"derivative":{"exercise_price":2.64,"exercise_date":"2020-06-20","expiration_date":"2029-06-20","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001387131-19-004583","document":"barlow-form4_062019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713119004583/barlow-form4_062019.xml","form_type":"4"}},{"id":3873827,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":30492,"kind":"person","name":"Barlow Jane F","position":1,"cik":"0001736026","reported_name":"Barlow Jane F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-07-05T21:00:20.000Z","date":"2018-07-02","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":6.35,"exercise_date":"2019-07-02","expiration_date":"2028-07-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001387131-18-003025","document":"barlow-form4_070218.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118003025/barlow-form4_070218.xml","form_type":"4"}},{"id":3961762,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":30492,"kind":"person","name":"Barlow Jane F","position":1,"cik":"0001736026","reported_name":"Barlow Jane F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-04-18T21:20:19.000Z","date":"2018-04-17","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":5.72,"exercise_date":"2018-06-30","expiration_date":"2028-04-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001387131-18-001647","document":"barlow-form4_041718.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118001647/barlow-form4_041718.xml","form_type":"4"}}]}